BioRestorative Therapies, Inc.

US$1.52As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BRTXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (70.09%)
Div yield —
ROE (241.14%)
Biotechnology
Beta (5Y) 0.84
PE TTM —
TSR TTM (95.06%)
Mkt cap US$1.936M
ROIC (193.30%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.73
13.70%
(15.05%)
Hold 11|8|5|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
1.62%
(2.77%)
8.67%
5.22%
Revenue$M
0.212
0.224
0.225
0.234
12.94%
14.30%
9.79%
8.59%
Peers (US$1.936M)
Cap (US$)
PE
2.112M
—
1.697M
—
Capital
TTM
5Y
10Y
Leveragex
0.377
0.690
0.655
EBIT/Intx
0.891
0.294
0.271
Own earn%
(17.41)
(61.41)
(64.26)
Sh yield%
24.18
49.12
45.91
Owners
Insiders/Inst%
3.95
60.62
Short interest%
3.34
SBC / revenue%
2.51
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
13–16
$1 testx
—
Incr. ROIC%
30